# Phase 1 Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of ATOR-1017

> **NCT04144842** · PHASE1 · COMPLETED · sponsor: **Alligator Bioscience AB** · enrollment: 27 (actual)

## Conditions studied

- Solid Tumor
- Neoplasms

## Interventions

- **BIOLOGICAL:** ATOR-1017

## Key facts

- **NCT ID:** NCT04144842
- **Lead sponsor:** Alligator Bioscience AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-03
- **Primary completion:** 2023-03-29
- **Final completion:** 2023-03-29
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2023-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04144842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04144842, "Phase 1 Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of ATOR-1017". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04144842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*